LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | PI103 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4398 | 5505 | 0.7989 | 0.7122 |
BT-20 | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5379 | 5505 | 0.9771 | 0.9673 |
BT-20 | QL-X-138 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 3985 | 5505 | 0.7239 | 0.6049 |
BT-20 | QL-XII-47 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4361 | 5505 | 0.7922 | 0.7026 |
BT-20 | Radicicol | 0.12 | uM | LJP5 | 72 | hr | 1657 | 3436 | 5505 | 0.6242 | 0.4623 |
BT-20 | Radicicol | 0.12 | uM | LJP6 | 72 | hr | 1657 | 3337 | 5505 | 0.6062 | 0.4365 |
BT-20 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5585 | 5505 | 1.0144 | 1.0206 |
BT-20 | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5224 | 5505 | 0.9490 | 0.9270 |
BT-20 | XL147 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5761 | 5505 | 1.0465 | 1.0665 |
BT-20 | Saracatinib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5246 | 5505 | 0.9528 | 0.9325 |
BT-20 | Selumetinib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5592 | 5505 | 1.0157 | 1.0225 |
BT-20 | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 1657 | 3617 | 5505 | 0.6570 | 0.5093 |
BT-20 | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 1657 | 4954 | 5505 | 0.8999 | 0.8568 |
BT-20 | SU11274 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5749 | 5505 | 1.0443 | 1.0633 |
BT-20 | Fedratinib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5395 | 5505 | 0.9800 | 0.9714 |
BT-20 | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5209 | 5505 | 0.9462 | 0.9230 |
BT-20 | Torin1 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 2103 | 5505 | 0.3820 | 0.1157 |
BT-20 | Torin2 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 1522 | 5505 | 0.2766 | -0.0351 |
BT-20 | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 1979 | 5505 | 0.3595 | 0.0836 |
BT-20 | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 4415 | 5505 | 0.8020 | 0.7167 |
BT-20 | TWS119 | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5347 | 5505 | 0.9713 | 0.9589 |
BT-20 | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5716 | 5505 | 1.0383 | 1.0548 |
BT-20 | Withaferin A | 0.12 | uM | LJP5 | 72 | hr | 1657 | 5464 | 5505 | 0.9924 | 0.9892 |
BT-20 | Withaferin A | 0.12 | uM | LJP6 | 72 | hr | 1657 | 5355 | 5505 | 0.9727 | 0.9609 |
BT-20 | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 1657 | 2553 | 5505 | 0.4637 | 0.2327 |